Zdrowie i gospodarka · 28/08/1997
Regulatory Workshop to Discuss Potency and Dosage of von Willebrand Factor Concentrates
The FDA is hosting a public workshop to discuss the potency and dosage of von Willebrand factor concentrates, which are used to treat bleeding disorders such as hemophilia A and von Willebrand disease.